Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
All cancer types, Bowel (colorectal) cancer, Lung cancer, Non small cell lung cancer (NSCLC), Ovarian cancer, Pancreatic cancer, Womb (uterine or endometrial) cancer
Closed
Phase 1
This trial is looking at defactinib with VS-6766 for solid cancers. A is any cancer apart from leukaemia, lymphoma and myeloma.
It is open to people who can’t have or don’t want to have the for their cancer.
Recruitment start: 6 December 2017
Recruitment end: 31 January 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Udai Banerji
Institute of Cancer Research (ICR)
Chugai Pharma UK Ltd
Verastem Inc
Last reviewed: 31 January 2023
CRUK internal database number: 17248